Brian W. Behm

Costa, D. V. S., Pham, N., Loureiro, A. V., Yang, S. E., Behm, B. W., & Warren, C. A. (2024). Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease. ANAEROBE, 87. doi:10.1016/j.anaerobe.2024.102837

Ramakrishnan, G., Young, M. K., Nayak, U., Rigo, I., Marrs, A. S., Gilchrist, C. A., . . . Petri, W. A. (2024). Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infection. ANAEROBE, 87. doi:10.1016/j.anaerobe.2024.102840

Warren, C. A., Shin, J. H., Bansal, E. N., Costa, D. V. D. S., Wang, X. Q., Wu, M., . . . Archbald-Pannone, L. (2023). Alanyl-glutamine supplementation for Clostridioides difficile infection treatment (ACT): a double-blind randomised controlled trial study protocol. BMJ OPEN, 13(7). doi:10.1136/bmjopen-2023-075721

Jain, V., Behm, B., & Figueroa, E. (2021). P022 Biologic Therapy and Therapeutic Drug Monitoring in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.. The American journal of gastroenterology, 116(Suppl 1), S5. doi:10.14309/01.ajg.0000798688.16985.68

Jain, V., Behm, B., & Figueroa, E. (2021). P022 Biologic Therapy and Therapeutic Drug Monitoring in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.. The American journal of gastroenterology, 116(Suppl 1), S5. doi:10.14309/01.ajg.0000798688.16985.68

Jan, N., Hays, R. A., Oakland, D. N., Kumar, P., Ramakrishnan, G., Behm, B. W., . . . Marie, C. (2021). Fecal Microbiota Transplantation Increases Colonic IL-25 and Dampens Tissue Inflammation in Patients with Recurrent Clostridioides difficile. MSPHERE, 6(5). doi:10.1128/mSphere.00669-21

Tyler, C. J., Guzman, M., Lundborg, L. R., Yeasmin, S., Perez-Jeldres, T., Yarur, A., . . . Rivera-Nieves, J. (2020). Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design. JOURNAL OF CROHNS & COLITIS, 14(10), 1364-1377. doi:10.1093/ecco-jcc/jjaa067

Auerbach, M., Behm, B. W., & Sankineni, A. (2020). Treatment of Iron Deficiency in Gastroenterology: A New Paradigm. PRACTICAL GASTROENTEROLOGY, 44(1), 18-25. Retrieved from https://www.webofscience.com/

Wang, J., Nakamura, T. I., Tuskey, A. G., & Behm, B. W. (2019). Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study. INTESTINAL RESEARCH, 17(4), 496-503. doi:10.5217/ir.2019.00050

Chitnavis, M. V., Baray, M., Northup, P. G., Tuskey, A. G., & Behm, B. W. (2019). Opioid use and misuse in ulcerative colitis.. World journal of gastrointestinal pharmacology and therapeutics, 10(1), 22-28. doi:10.4292/wjgpt.v10.i1.22

Wentworth, B. J., Buerlein, R. C. D., Tuskey, A. G., Overby, M. A., Smolkin, M. E., & Behm, B. W. (2018). Nonadherence to Biologic Therapies in Inflammatory Bowel Disease. INFLAMMATORY BOWEL DISEASES, 24(9), 2053-2061. doi:10.1093/ibd/izy102

Stine, J. G., Wang, J., Cornella, S. L., Behm, B. W., Henry, Z., Shah, N. L., . . . Northup, P. G. (2018). Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial.. Annals of hepatology, 17(2), 300-306. doi:10.5604/01.3001.0010.8661

Stine, J. G., Wang, J., Cornelia, S. L., Behm, B. W., Henry, Z., Shah, N. L., . . . Northup, P. G. (2018). Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial. ANNALS OF HEPATOLOGY, 17(2), 300-306. doi:10.5604/01.3001.0010.8661

Niccum, B. A., Stein, D. J., Behm, B. W., & Hays, R. A. (2018). Zinc Deficiency and the Recurrence of Clostridium difficile Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study. JOURNAL OF NUTRITION AND METABOLISM, 2018. doi:10.1155/2018/9682975

Copland, A. P., Behm, B., & Parrish, C. R. (2017). Seeking Enteral Autonomy with Teduglutide. PRACTICAL GASTROENTEROLOGY, 41(9), 41-52. Retrieved from https://www.webofscience.com/

Chitnavis, M., Stein, D. J., Commins, S., Schuyler, A. J., & Behm, B. (2017). First-dose anaphylaxis to infliximab: a case of mammalian meat allergy. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 5(5), 1425-1426. doi:10.1016/j.jaip.2017.04.044

deFonseka, A. M., Tuskey, A., Conaway, M. R., & Behm, B. W. (2016). Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease. JOURNAL OF CLINICAL GASTROENTEROLOGY, 50(7), 578-583. doi:10.1097/MCG.0000000000000408

Stine, J. G., Wang, J., & Behm, B. W. (2016). Chronic Cholestatic Liver Injury Attributable to Vedolizumab. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 4(3), 277-280. doi:10.14218/JCTH.2016.00018

Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., . . . PREVENT Study Group. (2016). Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.. Gastroenterology, 150(7), 1568-1578. doi:10.1053/j.gastro.2016.02.072

Mosli, M. H., MacDonald, J. K., Bickston, S. J., Behm, B. W., Tsoulis, D. J., Cheng, J., . . . Feagan, B. G. (2015). Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis. INFLAMMATORY BOWEL DISEASES, 21(5), 1151-1159. doi:10.1097/MIB.0000000000000396

Crocker, J. A., Yu, H., Conaway, M., Tuskey, A. G., & Behm, B. W. (2014). Narcotic Use and Misuse in Crohn's Disease. INFLAMMATORY BOWEL DISEASES, 20(12), 2234-2238. doi:10.1097/MIB.0000000000000194

Bickston, S. J., Behm, B. W., Tsoulis, D. J., Cheng, J., MacDonald, J. K., Khanna, R., & Feagan, B. G. (2014). Vedolizumab for induction and maintenance of remission in ulcerative colitis. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (8). doi:10.1002/14651858.CD007571.pub2

Tuskey, A., & Behm, B. W. (2014). Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease. CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 7, 173-179. doi:10.2147/CEG.S39518

Tekola, B. D., Arner, D. M., & Behm, B. W. (2013). Coil migration after transarterial coil embolization of a splenic artery pseudoaneurysm.. Case reports in gastroenterology, 7(3), 487-491. doi:10.1159/000357151

McConnell, J., Parvulescu-Codrea, S., Behm, B., Hill, B., Dunkle, E., Finke, K., . . . Woodward, B. (2012). Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness.. World journal of gastrointestinal pharmacology and therapeutics, 3(5), 74-82. doi:10.4292/wjgpt.v3.i5.74

Behm, B. W., & Peura, D. A. (2011). Dexlansoprazole MR for the management of gastroesophageal reflux disease. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 5(4), 439-445. doi:10.1586/EGH.11.37

Wang, A. Y., Sauer, B. G., Behm, B. W., Ramanath, M., Cox, D. G., Ellen, K. L., . . . Kahaleh, M. (2011). Single-balloon or short double-balloon enteroscope for ERCP in patients with surgically altered anatomies Response. GASTROINTESTINAL ENDOSCOPY, 73(2), 416-417. doi:10.1016/j.gie.2010.07.021

Wang, A. Y., Sauer, B. G., Behm, B. W., Ramanath, M., Cox, D. G., Ellen, K. L., . . . Kahaleh, M. (2010). Single-balloon enteroscopy effectively enables diagnostic and therapeutic retrograde cholangiography in patients with surgically altered anatomy. GASTROINTESTINAL ENDOSCOPY, 71(3), 641-649. doi:10.1016/j.gie.2009.10.051